ArticleTrials2026

Efficacy and safety of SarogLItazar as an add-on medication to Metformin and lifestyle intervention in women with PolyCystic Ovary Syndrome (SLIM-PCOS trial): study protocol for a randomized, open-label, parallel group clinical trial.

Niti Mittal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.